{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:44:07Z","timestamp":1792511047902,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2401105"],"award-info":[{"award-number":["2021YFC2401105"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004763","name":"Natural Science Foundation of Inner Mongolia Autonomous Region","doi-asserted-by":"publisher","award":["2020MS01819"],"award-info":[{"award-number":["2020MS01819"]}],"id":[{"id":"10.13039\/501100004763","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373033"],"award-info":[{"award-number":["82373033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04430-z","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:35:02Z","timestamp":1784878502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative proteomic landscape reveals the role of CSPG5 in the recurrence of glioma"],"prefix":"10.1186","volume":"26","author":[{"given":"Shijian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baorui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"4430_CR1","doi-asserted-by":"publisher","unstructured":"Stupp R et al. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial, JAMA, vol. 318, no. 23, pp. 2306\u20132316, Dec 2017, https:\/\/doi.org\/10.1001\/jama.2017.18718","DOI":"10.1001\/jama.2017.18718"},{"key":"4430_CR2","doi-asserted-by":"publisher","unstructured":"Chinot OL, et al. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med. Feb 2014;370:709\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1308345.","DOI":"10.1056\/NEJMoa1308345"},{"key":"4430_CR3","doi-asserted-by":"publisher","unstructured":"Gilbert MR, et al. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol. Nov 2013;31:4085\u201391. https:\/\/doi.org\/10.1200\/jco.2013.49.6968.","DOI":"10.1200\/jco.2013.49.6968"},{"key":"4430_CR4","doi-asserted-by":"publisher","unstructured":"Petrecca K, Guiot MC, Panet-Raymond V, Souhami L. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. J Neurooncol. Jan 2013;111(1):19\u201323. https:\/\/doi.org\/10.1007\/s11060-012-0983-4.","DOI":"10.1007\/s11060-012-0983-4"},{"key":"4430_CR5","doi-asserted-by":"publisher","unstructured":"Knudsen AM, et al. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors. Neuro-Oncol. Jul 2022;24(7):1074\u201387. https:\/\/doi.org\/10.1093\/neuonc\/noab302.","DOI":"10.1093\/neuonc\/noab302"},{"key":"4430_CR6","doi-asserted-by":"publisher","unstructured":"Jadhav V, Zhang JH. Surgical brain injury: prevention is better than cure. Front Biosci. May 2008;13:3793\u20137. https:\/\/doi.org\/10.2741\/2968.","DOI":"10.2741\/2968"},{"key":"4430_CR7","doi-asserted-by":"publisher","unstructured":"Bao Z, et al. Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution. Front Med. Aug 2021;15(4):551\u201361. https:\/\/doi.org\/10.1007\/s11684-020-0760-2.","DOI":"10.1007\/s11684-020-0760-2"},{"key":"4430_CR8","doi-asserted-by":"publisher","unstructured":"Choi S, Yu Y, Grimmer MR, Wahl M, Chang SM, Costello JF. Temozolomide-associated hypermutation in gliomas. Neuro-Oncol. Sep 2018;20(10):1300\u20139. https:\/\/doi.org\/10.1093\/neuonc\/noy016.","DOI":"10.1093\/neuonc\/noy016"},{"key":"4430_CR9","doi-asserted-by":"publisher","unstructured":"Kim H, et al. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution. Genome Res. Mar 2015;25(3):316\u201327. https:\/\/doi.org\/10.1101\/gr.180612.114.","DOI":"10.1101\/gr.180612.114"},{"key":"4430_CR10","doi-asserted-by":"publisher","unstructured":"Chen J, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. Aug 2012;488(7412):522\u20136. https:\/\/doi.org\/10.1038\/nature11287.","DOI":"10.1038\/nature11287"},{"key":"4430_CR11","doi-asserted-by":"publisher","unstructured":"Wang L, et al. A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets. Nat Cancer. Dec 2022;3(12):1534\u201352. https:\/\/doi.org\/10.1038\/s43018-022-00475-x.","DOI":"10.1038\/s43018-022-00475-x"},{"key":"4430_CR12","doi-asserted-by":"publisher","unstructured":"Sch\u00e4fer N, et al. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors. J Transl Med. Mar 2019;17(1):96. https:\/\/doi.org\/10.1186\/s12967-019-1846-y.","DOI":"10.1186\/s12967-019-1846-y"},{"key":"4430_CR13","doi-asserted-by":"publisher","unstructured":"Walsh FS, Doherty P. Cell adhesion molecules and neuronal regeneration. Curr Opin Cell Biol. Oct 1996;8(5):707\u201313. https:\/\/doi.org\/10.1016\/s0955-0674(96)80113-x.","DOI":"10.1016\/s0955-0674(96)80113-x"},{"key":"4430_CR14","doi-asserted-by":"publisher","unstructured":"Jiang Y et al. The coming era of proteomics-driven precision medicine, Natl. Sci. Rev., vol. 12, no. 8, p. nwaf278, Aug 2025, https:\/\/doi.org\/10.1093\/nsr\/nwaf278","DOI":"10.1093\/nsr\/nwaf278"},{"key":"4430_CR15","doi-asserted-by":"publisher","unstructured":"Oohira A, Matsui F, Tokita Y, Yamauchi S, Aono S. Molecular interactions of neural chondroitin sulfate proteoglycans in the brain development. Arch Biochem Biophys. Feb 2000;374(1):24\u201334. https:\/\/doi.org\/10.1006\/abbi.1999.1598.","DOI":"10.1006\/abbi.1999.1598"},{"key":"4430_CR16","doi-asserted-by":"publisher","unstructured":"Kinugasa Y, Ishiguro H, Tokita Y, Oohira A, Ohmoto H, Higashiyama S. Neuroglycan C, a novel member of the neuregulin family, Biochem. Biophys. Res. Commun., vol. 321, no. 4, pp. 1045-9, Sep 3 2004, https:\/\/doi.org\/10.1016\/j.bbrc.2004.07.066","DOI":"10.1016\/j.bbrc.2004.07.066"},{"key":"4430_CR17","doi-asserted-by":"publisher","unstructured":"Schumacher S, et al. CALEB binds via its acidic stretch to the fibrinogen-like domain of tenascin-C or tenascin-R and its expression is dynamically regulated after optic nerve lesion. J Biol Chem. Mar 2001;276(10):7337\u201345. https:\/\/doi.org\/10.1074\/jbc.M007234200.","DOI":"10.1074\/jbc.M007234200"},{"key":"4430_CR18","doi-asserted-by":"publisher","unstructured":"Tsidulko AY, et al. Chondroitin sulfate content and decorin expression in glioblastoma are associated with proliferative activity of glioma cells and disease prognosis. Cell Tissue Res. Jan 2020;379(1):147\u201355. https:\/\/doi.org\/10.1007\/s00441-019-03127-2.","DOI":"10.1007\/s00441-019-03127-2"},{"key":"4430_CR19","doi-asserted-by":"publisher","unstructured":"Su T, Zhang P, Zhao F, Zhang S. A novel immune-related prognostic signature in epithelial ovarian carcinoma. Aging. Apr 2021;13(7):10289\u2013311. https:\/\/doi.org\/10.18632\/aging.202792.","DOI":"10.18632\/aging.202792"},{"key":"4430_CR20","doi-asserted-by":"publisher","first-page":"666199","DOI":"10.3389\/fonc.2021.666199","volume":"11","author":"C Yuan","year":"2021","unstructured":"Yuan C, et al. Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma. Front Oncol. 2021;11:666199. https:\/\/doi.org\/10.3389\/fonc.2021.666199.","journal-title":"Front Oncol"},{"key":"4430_CR21","doi-asserted-by":"publisher","unstructured":"Gobin M, et al. A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications. Cancer Res. Mar 2019;79:1226\u201338. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-2076.","DOI":"10.1158\/0008-5472.Can-18-2076"},{"issue":"6","key":"4430_CR22","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1093\/nar\/gkm099","volume":"35","author":"F Vikhanskaya","year":"2007","unstructured":"Vikhanskaya F, Lee MK, Mazzoletti M, Broggini M, Sabapathy K. Cancer-derived p53 mutants suppress p53-target gene expression\u2013potential mechanism for gain of function of mutant p53. Nucleic Acids Res. 2007;35(6):2093\u2013104. https:\/\/doi.org\/10.1093\/nar\/gkm099.","journal-title":"Nucleic Acids Res"},{"key":"4430_CR23","doi-asserted-by":"publisher","unstructured":"Zhao Z, et al. Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients. Genomics Proteom Bioinf. Feb 2021;19(1):1\u201312. https:\/\/doi.org\/10.1016\/j.gpb.2020.10.005.","DOI":"10.1016\/j.gpb.2020.10.005"},{"key":"4430_CR24","doi-asserted-by":"publisher","unstructured":"J\u00fcttner R et al. Impaired synapse function during postnatal development in the absence of CALEB, an EGF-like protein processed by neuronal activity, Neuron, vol. 46, no. 2, pp. 233\u2013245, Apr 2005, https:\/\/doi.org\/10.1016\/j.neuron.2005.02.027","DOI":"10.1016\/j.neuron.2005.02.027"},{"key":"4430_CR25","doi-asserted-by":"publisher","unstructured":"Yoo WS et al. Role of Chondroitin Sulfate Proteoglycan 5 in Steroid-Induced Cataract, Cells, vol. 12, no. 13, Jun 2023, https:\/\/doi.org\/10.3390\/cells12131705","DOI":"10.3390\/cells12131705"},{"key":"4430_CR26","doi-asserted-by":"publisher","unstructured":"Schumacher S, et al. Chicken acidic leucine-rich EGF-like domain containing brain protein (CALEB), a neural member of the EGF family of differentiation factors, is implicated in neurite formation. J Cell Biol. Feb 1997;136(4):895\u2013906. https:\/\/doi.org\/10.1083\/jcb.136.4.895.","DOI":"10.1083\/jcb.136.4.895"},{"key":"4430_CR27","doi-asserted-by":"publisher","unstructured":"Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor, Cell, vol. 110, no. 6, pp. 669\u2013672, Sep 2002, https:\/\/doi.org\/10.1016\/s0092-8674(02)00966-2","DOI":"10.1016\/s0092-8674(02)00966-2"},{"key":"4430_CR28","doi-asserted-by":"publisher","unstructured":"Bublil EM, Yarden Y. The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr Opin Cell Biol. Apr 2007;19(2):124\u201334. https:\/\/doi.org\/10.1016\/j.ceb.2007.02.008.","DOI":"10.1016\/j.ceb.2007.02.008"},{"key":"4430_CR29","doi-asserted-by":"publisher","first-page":"188721","DOI":"10.1016\/j.bbcan.2022.188721","volume":"1877","author":"T Pienkowski","year":"2022","unstructured":"Pienkowski T, et al. Proteomics and metabolomics approach in adult and pediatric glioma diagnostics. Biochim Biophys Acta Rev Cancer. 2022;1877:188721. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188721.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4430_CR30","doi-asserted-by":"publisher","first-page":"339695","DOI":"10.1016\/j.aca.2022.339695","volume":"1204","author":"K Weke","year":"2022","unstructured":"Weke K, et al. DIA-MS proteome analysis of formalin-fixed paraffin-embedded glioblastoma tissues. Anal Chim Acta. 2022;1204:339695. https:\/\/doi.org\/10.1016\/j.aca.2022.339695.","journal-title":"Anal Chim Acta"},{"key":"4430_CR31","doi-asserted-by":"publisher","unstructured":"Lam MSY et al. Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood-Brain Barrier and Glioblastoma, Small, vol. 19, p. 2302280, 2023, https:\/\/doi.org\/10.1002\/smll.202302280","DOI":"10.1002\/smll.202302280"},{"key":"4430_CR32","doi-asserted-by":"publisher","first-page":"vdaf258","DOI":"10.1093\/noajnl\/vda258","volume":"8","author":"C-J Kihlstedt","year":"2026","unstructured":"Kihlstedt C-J, et al. Proteomics in IDH-mutated diffuse lower-grade glioma: A scoping review. Neuro-Oncol Adv. 2026;8:vdaf258. https:\/\/doi.org\/10.1093\/noajnl\/vda258.","journal-title":"Neuro-Oncol Adv"},{"key":"4430_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.nicl.2016.02.016","volume":"11","author":"T Kazda","year":"2016","unstructured":"Kazda T, et al. Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: Single institution thresholds and validation of MR spectroscopy and diffusion weighted MR imaging. Neuroimage Clin. 2016;11:316\u201321. https:\/\/doi.org\/10.1016\/j.nicl.2016.02.016.","journal-title":"Neuroimage Clin"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04430-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04430-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04430-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:02:07Z","timestamp":1792508527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04430-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4430"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04430-z","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Research Ethics Committee of the Chinese PLA General Hospital (approval No. S2021-129-01, date: 2021). Written informed consent was obtained from all 63 patients for the use of their paired primary and recurrent formalin-fixed paraffin-embedded (FFPE) glioma tissues and associated clinical data.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"343"}}